# Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/economic-burden-and-healthcare-utilization-associated-with-castration-resistant/

## Facts

| Field | Value |
| --- | --- |
| Author Names | B. Alemayehu,Erin Buysman,David Parry,Laura Becker,Faith E. Nathan |
| Citations | 48 |
| DOI | 10.3111/13696998.2010.491435 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.tandfonline.com/doi/pdf/10.3111/13696998.2010.491435?needAccess=true |
| OpenAlex ID | https://openalex.org/W2171043360 |
| PMID | 20491610 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Erin Buysman](https://scholariq.org/researchers/erin-buysman/)

## Paper journal

- [Journal of Medical Economics](https://scholariq.org/journals/journal-of-medical-economics/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.